Celina Ang

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida et al. · Hepatology · 2022 · 218 citations · Full text

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

Celina Ang, Samuel J. Klempner, Siraj M. Ali et al. · Oncotarget · 2019 · 164 citations · Full text

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy

Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin et al. · Cancer Medicine · 2020 · 129 citations · Full text

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Sofya Pintova, Sirish Dharmupari, Erin Moshier et al. · Cancer Chemotherapy and Pharmacology · 2019 · 122 citations

Gastrointestinal Oncology, Medicine, Pharmacology +8

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola et al. · Oncogene · 2018 · 114 citations · Full text

Plasma Dna, Sequencing, Health Sciences +12